Summary of ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’
Evidence-Based Child Health: A Cochrane Review Journal · 2006
DOI: 10.1002/ebch.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-Based Child Health: A Cochrane Review Journal, 2006. Verfasst von Jilleen Kosko.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This is a summary of a Cochrane review, published in this issue of EBCH, first published as: Mitta A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD001276. DOI: 10.1002/14651858.CD001276.pub2. Copyright © 2006 John Wiley & Sons, Ltd.
Zitieren
APA
Kosko, J. (2006). Summary of ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’. Evidence-Based Child Health: A Cochrane Review Journal. https://doi.org/10.1002/ebch.11
Vancouver
Kosko J. Summary of ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’. Evidence-Based Child Health: A Cochrane Review Journal. 2006. doi:10.1002/ebch.11
BibTeX
@article{Kosko2006,
author = {Kosko, Jilleen},
title = {Summary of ‘Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators’},
journal = {Evidence-Based Child Health: A Cochrane Review Journal},
year = {2006},
doi = {10.1002/ebch.11}
}
EUVIMED